You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Aerophilic-electrode-based Membrane Free Electrolyzer (AMeFE)
SBC: CHROMOLOGIC LLC Topic: CBD203002In order to address DoDâs urgent need for decentralized generation of hydrogen peroxide for decontamination on remote sites, ChromoLogic LLC (CL) proposes to develop an aerophilic-electrode-based membrane free electrolyzer (AMeFE) as a light-weight, energy saving, and high efficiency H2O2 generator to support application of SEDS. Electrolyte applied in AMeFE will maintain an optimal solution ...
SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids
SBC: INTELLIGENT OPTICAL SYSTEMS, INC. Topic: CBD20AT001Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Development of Small Molecule Therapeutics for Emerging Viral Agents
SBC: ARISAN THERAPEUTICS INC Topic: CBD192006Ebolavirus species including Zaire (EBOV), Sudan (SUDV) and Bundibugyo (BDBV) are responsible for severe hemorrhagic fever outbreaks with high case fatalities in Africa. Weaponized pathogens present an additional threat to the health protection of the warfighter and first-generation prophylactic and therapeutic medical countermeasures (MCMs) may prove inadequate in biodefense settings. Ebolaviruse ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Augmented reality and data fusion for CBRN threats
SBC: Gamma Reality Inc. Topic: CBD212002One of the hallmarks of our modern world is the increasing ubiquity of sensors and platforms deployed in complex environments. On the battlefield, there are a wide variety of sensors integrated with platforms ranging from large vehicles, such as the NBCRV, to drones, ground robots, light tactical off road vehicles, and on the Warfighters themselves. Collecting, correlating, analyzing, and communic ...
SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense -
PlumeSight: A machine learning based plume identification and classification method for LIDAR instrument data
SBC: MICHIGAN AEROSPACE CORP Topic: CBD202002LIDAR is a powerful tool for the measurement and characterization of aerosols in the atmosphere. In battlefield environments, a wide variety of aerosol constituents and plume types are present. Traditional LIDAR analysis methods aim to characterize plumes in well controlled environments with a minimum of atmospheric clutter. To extend the abilities of plume characterization and identification in c ...
SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Self-contained Equipment Decontamination System (SCEDS)
SBC: Integrated Solutions for Systems, Inc. Topic: CBD192002The processes and systems required to decontaminate personnel have received much attention and several effective systems exist. However, decontamination of sensitive equipment, without damage or performance degradation, is a significantly different problem that has not been adequately solved. The wide variety of electronics, fabrics and structural materials together with the infinite variations in ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Development of a Non-invasive Negative Ophthalmodynamometer Capable of Measuring Intracranial Pressure in Humans
SBC: Equinox Ophthalmic, Inc. Topic: CBD192005Measurement of intracranial pressure (ICP) is essential in the diagnosis and management of numerous life threatening conditions. All current methods used clinically to measure ICP are invasive and require direct access to the cerebrospinal fluid giving them a significant side effect profile. The ability to measure ICP non-invasively would be a major milestone for patients. Spontaneous venous pulsa ...
SBIR Phase I 2020 Department of DefenseOffice for Chemical and Biological Defense -
Electrospray Capture & Detection of Bioaerosols
SBC: CONNECTICUT ANALYTICAL CORP Topic: CBD212003The recent COVID-19 world pandemic demonstrates most effectively the urgent need for near real-time detection of ambient airborne pathogens. It has been demonstrated that electrospray ionization, utilized in many mass spectrometers today, has the unique ability to capture bioaerosols non-destructively out of the air for subsequent interrogation. This proposal leverages on this electrospray capture ...
SBIR Phase I 2022 Department of DefenseOffice for Chemical and Biological Defense -
Austere environment, durable, safe, glass equivalent auto injector container technology
SBC: SIO2 MEDICAL PRODUCTS INC Topic: CBD202003SiO2 Materials Science (SiO2) is a U.S. advanced medical technology company that produces high-performance, durable, glass-equivalent primary containers that are uniquely designed to store, transport, and protect drugs, including those that require cold-chain storage. SiO2 is an SBA Defense SBIR/STTR Innovation Portal (DSIP) small business. SiO2âs primary containers are wholly manufactured in ...
SBIR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001The modern warfighter faces the constant threat of endemic infections, multi-drug resistant bacteria and Biological Warfare Agents. In order to provide accurate front-line treatment that will curtail the overuse of antibiotics, a rapid and robust molecula
STTR Phase I 2016 Department of DefenseOffice for Chemical and Biological Defense